Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ

Revenue (LTM)

Net Income (LTM)

$-60M

-41.9% YoY

Free Cash Flow

$-56M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	50	0	0
Gross Profit	0	-0	50↑15297.6%	-0↓100.5%	-0↓25.2%
Operating Income	-29	-23↑20.7%	-16↑29.2%	-51↓216.6%	-68↓33.7%
Net Income	-29	-24↑16.4%	23↑193.7%	-42↓286.0%	-60↓41.9%
EBITDA	-28	-24↑16.9%	24↑200.2%	-42↓278.2%	-68↓62.0%
EPS Diluted	-1.15	-0.97↑15.7%	0.90↑192.8%	-2.18↓342.2%	-2.17↑0.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	5	6↑20.3%	16↑178.8%	22↑41.3%	76↑244.5%
Total Current Assets	70	48↓30.6%	128↑163.9%	206↑61.6%	268↑29.8%
Total Assets	71	51↓28.2%	130↑157.5%	213↑63.2%	277↑30.0%
Total Current Liabilities	4	8↑105.5%	5↓27.4%	10↑81.9%	10↓2.3%
Total Liabilities	9	11↑27.3%	198↑1644.9%	15↓92.5%	16↑5.9%
Total Equity	62	39↓36.2%	-68↓273.0%	198↑391.5%	261↑31.8%
Total Debt	5	6↑19.1%	193↑3203.0%	6↓96.8%	8↑31.8%
Net Debt	0	0↑0.4%	178↑63352.1%	-16↓108.8%	-67↓329.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-26	-20↑23.4%	19↑196.2%	-33↓269.8%	-55↓68.4%
Capital Expenditure	-0	-0↑29.8%	-0↓250.8%	-1↓24.2%	-0↑55.1%
Free Cash Flow	-26	-20↑23.4%	19↑193.6%	-33↓276.2%	-56↓66.5%
Stock-Based Comp	2	2↑10.2%	2↑15.2%	7↑206.6%	10↑47.5%
Net Change in Cash	-11	1↑108.2%	10↑960.4%	6↓35.6%	54↑736.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance